Gujarat, India

Nimeshkumar Mukeshkumar Shah

This inventor holds 2 USPTO granted patents. Top assignee: Cadila Healthcare Limited. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nimeshkumar Mukeshkumar Shah. Retrieved from https://idiyas.com/inventor/nimeshkumar-mukeshkumar-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nimeshkumar Mukeshkumar Shah: Innovator in Pharmaceutical Processes

Introduction

Nimeshkumar Mukeshkumar Shah is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of apalutamide. With a total of 2 patents to his name, Shah's work is recognized for its innovative approach to drug formulation.

Latest Patents

Shah's latest patents focus on the process for the preparation of apalutamide. The present invention relates to a method for synthesizing apalutamide and its intermediates. Additionally, it encompasses pharmaceutical compositions that include apalutamide, showcasing his commitment to advancing medical treatments.

Career Highlights

Nimeshkumar Mukeshkumar Shah is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug development and innovation.

Collaborations

Shah has collaborated with notable colleagues, including Kumar Kamlesh Singh and Nikhil Amar Singh. These partnerships enhance the collaborative spirit of innovation within the pharmaceutical sector.

Conclusion

Nimeshkumar Mukeshkumar Shah stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative processes for drug preparation. His contributions are paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…